Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,250 across all filing types
Latest filing 2019-03-12 Share Issue/Capital Cha…
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
关于发行股份购买资产并募集配套资金之限售股份上市流通的提示性公告
Share Issue/Capital Change Classification · 95% confidence The document is a detailed announcement regarding the lifting of restrictions on certain shares previously issued under a private placement and asset purchase transaction. It includes specifics about the number of shares becoming freely tradable, the shareholders involved, compliance with regulatory approvals, and the impact on the company's share capital structure. The document references approvals from the China Securities Regulatory Commission and Shenzhen Stock Exchange rules, and it includes an independent financial advisor's opinion confirming compliance. The document is not a full financial report, earnings release, or management discussion, but rather a regulatory announcement about share circulation and capital changes related to previously restricted shares. This fits best under the category of Share Issue/Capital Change (SHA), as it concerns the change in status of shares from restricted to freely tradable and the related capital structure update. The document length is 4326 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the classification is SHA with high confidence.
2019-03-12 Chinese
关于公司董事、高级管理人员减持计划的预披露公告
Director's Dealing Classification · 100% confidence The document is a pre-disclosure announcement regarding a planned reduction in shareholdings by company directors and senior management. It details the shareholders involved, the number of shares to be sold, the reasons for the sale, and compliance with relevant laws and regulations. There is no financial data, earnings information, or report content. The document is focused on insider share transactions by directors and executives, which fits the definition of Director's Dealing (DIRS). The document length is under 5,000 characters and is a formal announcement of planned insider share sales, not a financial report or earnings release.
2019-03-07 Chinese
2018年度业绩快报
Earnings Release Classification · 95% confidence The document is titled '2018年度业绩快报' which translates to '2018 Annual Performance Express Report' or '2018 Annual Earnings Quick Report'. It contains preliminary financial data for the year 2018, including revenue, profit, net assets, and earnings per share. The document explicitly states that the data is preliminary and unaudited, and that the final audited data will be disclosed in the annual report. This indicates it is a quick earnings release rather than a full annual report. The document length is 2323 characters, which is relatively short and consistent with an earnings release rather than a full annual report. The content focuses on key financial highlights and performance metrics for the year, typical of an Earnings Release (ER). Therefore, the document should be classified as an Earnings Release (ER).
2019-02-22 Chinese
关于发行股份购买资产之部分限售股份上市流通的提示性公告
Share Issue/Capital Change Classification · 95% confidence The document is a detailed announcement regarding the lifting of restrictions on certain shares previously issued as part of an asset purchase and fundraising. It includes specifics about the number of shares becoming tradable, the shareholders involved, their commitments, and the impact on the company's share structure. It references regulatory approvals and compliance with stock exchange rules. The document is not a financial report, earnings release, or management discussion, but rather a formal notification about share circulation changes related to restricted shares becoming freely tradable. This fits the category of Share Issue/Capital Change (SHA), as it concerns changes in share capital availability and circulation status.
2019-01-29 Chinese
关于子公司取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (846 characters) from a company about its subsidiary obtaining a medical device registration certificate. It contains no financial data, no detailed report, and no mention of financial results or management changes. It is an official company announcement about a regulatory approval related to product registration. The document is not a report, transcript, or financial filing but a regulatory announcement informing the market about a material event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-01-29 Chinese
中信证券股份有限公司关于公司发行股份购买资产并募集配套资金限售股上市流通之独立财务顾问核查意见
Capital/Financing Update Classification · 95% confidence The document is an independent financial advisor's verification opinion regarding the lifting of restrictions on the trading of restricted shares issued by SanNuo Bio-sensing Co., Ltd. It discusses the approval by the China Securities Regulatory Commission, details about the restricted shares, their release dates, shareholders' commitments, and compliance with relevant regulations. The document is not a full financial report but a specialized advisory opinion related to a capital market transaction involving restricted shares becoming tradable. It does not contain financial statements or quarterly/yearly financial results, nor is it a simple announcement of a report. It is a detailed advisory verification report related to capital issuance and share circulation restrictions. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (4793 characters) and content support this classification with high confidence.
2019-01-29 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.